News from the IBIS Board of Directors, April 2018
IBIS friends and colleagues,
A Hemochromatosis International Taskforce composed of experts in the field of hemochromatosis (headed by P. Santos and P. Brisssot) has composed and made public a consensus statement about “Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype.” The statement appeared recently, with open access, in Hepatology International.
The Board of Directors of IBIS, the International BioIron Society, endorse those recommendations, salutes the participants in the above task force and acknowledges the collaboration with Hemochomatosis International and other local and international societies open to cooperating with IBIS in the Study of Iron in Biology and Medicine.
Ioav Cabantchik (Professor Emeritus)
posted: April 2, 2018